<DOC>
	<DOCNO>NCT01968590</DOCNO>
	<brief_summary>This clinical trial conduct one 4 location ; University British Columbia ( Vancouver , CA ) , University Utah ( Salt Lake City , UT , USA ) , University Cincinnati ( Cincinnati , OH , USA ) , University Hamburg ( Hamburg , Germany ) . Adults NF1 high risk osteopenia osteoporosis , condition low bone density lead fragile bone bone breakage . People NF1 also low vitamin D level unaffected individual . Vitamin D important normal bone health , study improve bone health vitamin D supplementation people NF1 try . The purpose study treat adult NF1 insufficient serum vitamin D level 2 different dos vitamin D supplementation determine vitamin D supplementation ameliorate usual loss bone mineral density 2 year .</brief_summary>
	<brief_title>Vitamin D Supplementation Adults With Neurofibromatosis Type 1 ( NF1 )</brief_title>
	<detailed_description>Individuals NF1 vitamin D insufficiency supplement 2 different dos cholecalciferol ( vitamin D ) see loss bone mineral density lessen time . It important study vitamin carefully one would study medication , even though vitamin generally safer medication . For reason , carefully control trial two dos vitamin D perform 2-year period . It include controlled dos safety check participant ' health sure vitamin D supplementation safe people NF1 . Two different dos cholecalciferol , either 600 IU 4,000 IU ( IU mean `` International Units '' standard measure strength dose ) , use supplementation . The trial `` double blind '' . This mean neither participant investigator team know dose individual participant might randomize receive trial end . In emergency , however , investigator find . Participants randomize one dose , participant provide bottle liquid call `` D-drops '' dropper automatically drop measured amount bottle turn upside . Both dos vitamin D , 600 IU 4,000 IU , approve general population ; however , possible body people NF1 handle vitamin D differently . Therefore , safety measure assess trial . Any new medical issue concern throughout 2-year period need record assess study team . The primary measure study bone mineral density obtain bone densitometry ( DXA ) use low-dose xrays . Bone mineral density test begin end trial focus density bone hip spine . Secondary measure trial include questionnaire measure quality life history bone fracture . When someone insufficient serum vitamin D supplementation recommend , also supplement calcium . Therefore , participant give calcium supplement 400 mg elemental calcium per day . A diary keep daily track vitamin D calcium supplementation documentation fracture , occur , provide .</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>All individual NF1 ( neurofibromatosis type 1 ) , base NIH diagnostic criterion , age 25 40 year , may participate study . All participant enrol study screen serum 25 ( OH ) D level , individual level 9 29ng/ml ( inclusive ) eligible vitamin D supplementation 1. diagnosis Paget 's disease , hyperthyroidism , hyperparathyroidism , medical condition affect bone health 2. foresee unable comply twoyear study protocol 3 . Pregnant , plan conceive within next two year , less 6 month postdelivery lactation . 4. vitamin D supplementation last 3 month equal great 600IU per day 5. oral IV glucocorticoid use 3 month 6. bisphosphonate therapy 3 month 7. calcitonin therapy 3 month 8. calcium supplementation last 3 month equal great 1000mg per day 9. malignant peripheral nerve sheath tumor ( MPNST ) 10. history kidney stone last 5 year 11. individual metal instrumentation spine hip preclude accurate DXA interpretation . 12. inability obtain blood sample routine venipuncture 13. antiepileptic medical therapy 14. anticoagulant medical therapy</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Bone density</keyword>
</DOC>